Northern Trust Corp grew its stake in Teleflex Incorporated (NYSE:TFX) by 10.1% during the first quarter, HoldingsChannel reports. The firm owned 481,082 shares of the medical technology company’s stock after purchasing an additional 44,093 shares during the period. Northern Trust Corp’s holdings in Teleflex were worth $145,364,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Janney Montgomery Scott LLC raised its holdings in shares of Teleflex by 0.6% during the fourth quarter. Janney Montgomery Scott LLC now owns 9,256 shares of the medical technology company’s stock worth $2,393,000 after purchasing an additional 54 shares during the period. ETF Managers Group LLC grew its position in shares of Teleflex by 15.6% during the fourth quarter. ETF Managers Group LLC now owns 510 shares of the medical technology company’s stock worth $132,000 after acquiring an additional 69 shares during the last quarter. BB&T Securities LLC grew its position in shares of Teleflex by 86.0% during the fourth quarter. BB&T Securities LLC now owns 2,883 shares of the medical technology company’s stock worth $745,000 after acquiring an additional 1,333 shares during the last quarter. CIBC Private Wealth Group LLC grew its position in shares of Teleflex by 12.6% during the fourth quarter. CIBC Private Wealth Group LLC now owns 86,214 shares of the medical technology company’s stock worth $22,285,000 after acquiring an additional 9,622 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. grew its position in shares of Teleflex by 30.1% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 1,270 shares of the medical technology company’s stock worth $328,000 after acquiring an additional 294 shares during the last quarter. Institutional investors own 91.52% of the company’s stock.

In other news, VP Cameron P. Hicks sold 1,500 shares of the firm’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $298.14, for a total transaction of $447,210.00. Following the completion of the transaction, the vice president now owns 6,876 shares in the company, valued at approximately $2,050,010.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction dated Thursday, April 25th. The shares were sold at an average price of $277.14, for a total transaction of $55,428.00. Following the transaction, the director now owns 589 shares of the company’s stock, valued at approximately $163,235.46. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 44,400 shares of company stock valued at $13,235,810. Insiders own 2.36% of the company’s stock.

TFX traded up $3.44 on Wednesday, reaching $313.01. The company had a trading volume of 2,632 shares, compared to its average volume of 377,562. The firm has a market capitalization of $14.09 billion, a PE ratio of 31.59, a P/E/G ratio of 2.05 and a beta of 0.94. The company has a quick ratio of 1.41, a current ratio of 2.27 and a debt-to-equity ratio of 0.85. Teleflex Incorporated has a one year low of $226.02 and a one year high of $314.74.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $2.24 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.07. Teleflex had a net margin of 7.50% and a return on equity of 18.62%. The company had revenue of $613.60 million during the quarter, compared to analyst estimates of $608.27 million. During the same quarter last year, the firm posted $2.15 EPS. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. On average, equities analysts expect that Teleflex Incorporated will post 11.05 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be given a dividend of $0.34 per share. The ex-dividend date is Tuesday, May 14th. This represents a $1.36 annualized dividend and a dividend yield of 0.43%. Teleflex’s dividend payout ratio (DPR) is 13.74%.

Several equities analysts have recently commented on the stock. Needham & Company LLC restated a “buy” rating and set a $325.00 price target on shares of Teleflex in a research report on Tuesday, March 26th. Barclays upped their price target on shares of Teleflex from $287.00 to $309.00 and gave the stock an “equal weight” rating in a research report on Monday, April 15th. Wells Fargo & Co began coverage on shares of Teleflex in a research report on Tuesday. They issued an “outperform” rating and a $345.00 target price for the company. Zacks Investment Research lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Tuesday, May 14th. Finally, Raymond James increased their target price on shares of Teleflex from $320.00 to $348.00 and gave the company a “strong-buy” rating in a research report on Wednesday, March 27th. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. Teleflex has an average rating of “Buy” and an average price target of $330.00.

TRADEMARK VIOLATION NOTICE: This report was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2019/06/12/northern-trust-corp-buys-44093-shares-of-teleflex-incorporated-nysetfx.html.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Featured Story: Initial Public Offering (IPO)

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.